Souvien Therapeutics Company
Souvien Therapeutics is developing novel therapeutics to modulate critical epigenetic mechanisms associated with neurodegeneration.
Total Funding:
3500000
Headquarters:
Salt Lake City, Utah, United States
Estimated Revenue:
$10M to $50M
Last Funding Type:
Venture - Series Unknown
Technology:
Anti-infective Drugs
Last Funding Date:
2019
Investors Number:
1
Industry:
Biotechnology, Pharmaceutical